NP+PA PERSPECTIVES IN DERMATOLOGY
Lidose-Isotretinoin Administered Without Food Improves Quality of Life in Patients With Severe Recalcitrant Nodular Acne: An Open-Label, Single-Arm, Phase IV Study
J Clin Aesthet Dermatol. 2020;13(9):15–20 by Andrea L. Zaenglein, MD; Jeanett Segal, MD; Charles Darby, MSc; and James Q. Del Rosso, DO Dr. Zaenglein is with Departments of Dermatology and Pediatrics at Penn State College of Medicine, Hershey Medical Center in Hershey, Pennsylvania. Dr. Segal is with Sun Pharmaceutical Industries, Inc., in Princeton, New Jersey.
J Clin Aesthet Dermatol. 2020;13(9):26–32 by Hilary Baldwin, MD Dr. Baldwin is the Medical Director of the Acne Treatment and Research Center in Brooklyn, New York and is with Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey. ABSTRACT: Acne vulgaris is the most common dermatological disease in the United States, affecting up
J Clin Aesthet Dermatol. 2020;13(9):21–23 by Ahmed A. Saleh, MD; Aiham M. Al-Obaidi, MSc; Eman G. Behiry, MD; and Ahmed Mohammed Hamed, MD Mr. Al-Obaidi, Dr. Saleh, and Dr. Hamed are with the Department of Dermatology and Andrology of the Faculty of Medicine at Benha University in Benha, Egypt. Dr. Behiry is with the Department
J Clin Aesthet Dermatol. 2020;13(9):49–51 by Gabriella Vasile, DO; Mojgan Hosseinipour, DO; Cindy Hoffman, DO; and Charles Gropper, MD Dr. Vasile is a resident at Larkin Community Hospital of Palm Springs Dermatology in Hialeah, Florida. Dr. Hosseinipour is a Dermatology resident at St. Barnabas Hospital in Bronx, New York. Dr. Gropper is a Dermatologist at
Letter to the Editor: Recurrent pemphigus foliaceus at the site of a surgical scar following total knee arthroplasty
Dear Editor: We read the recent article, “Recurrence of Localized Pemphigus Foliaceus Induced by Knee Replacement,” with great interest.1 The authors attribute the presentation of unilateral pemphigus foliaceus (PF) in a previously uninvolved site to an immunocompromised district (ICD), where edema and nerve injury paved the way for a buildup of immunoglobulins and immune cells.
A 14-day Controlled Study Assessing Qualitative Improvement with 15% Lactic Acid and Ceramides in Skin Moisturization and Desquamation
by Zoe Diana Draelos, MD; Steven Hall, PharmD; and Carey Munsick, MS Dr. Draelos is with Dermatology Consulting Services, PLLC, in High Point, North Carolina. Dr. Hall and Ms. Munsick are with Sandoz Inc., in Princeton, New Jersey. J Clin Aesthet Dermatol. 2020;13(8):E54–E58 FUNDING: This study was funded by PharmaDerm, a division of Fougera Pharmaceuticals.
J Clin Aesthet Dermatol. 2020;13(7):E53–E57 by Daniele Maggioni, PhD; Annamaria Cimicata, MS; Antonella Praticò, MS; Roberta Villa, MS; Ferdinando Bianchi, MD; Silvia Busoli Badiale, MS; Umberto Piana; and Claudio Angelinetta All authors are with Bio Basic Europe in Milan, Italy. FUNDING: No funding was provided for this study. DISCLOSURES: The authors have no conflicts of
J Clin Aesthet Dermatol. 2020;13(7):E58–E63 by Patrícia Froes Meyer, PhD; Rodrigo Marcel Valentim da Silva, DO; Eneida de Morais Carreiro, MD; Bruna S. da Costa, BA; Débora Freire, BA; Júlio Davi Costa e Silva, BA; Stephany L. Queiroga Farias, BA; Rafaella Rêgo Maia, BA; Liliane Santos de Vasconcellos, MD; and Graziele Maia Alves Serafim, MD
J Clin Aesthet Dermatol. 2020;13(6):xx–xx by Sandrine Sebban, MD Dr. Sebban is in private practice in Paris, France. FUNDING: No funding was provided for this study. DISCLOSURES: The author owns shares in Soft Medical Aesthetics. ABSTRACT: Background. There is currently no standardized and reproducible injection technique to address facial aging at all anatomical levels. Objective. The Sebban
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study
Background. Vitiligo is an acquired disorder characterized by depigmented macules or patches on the skin due to the loss of functional melanocytes. Segmental vitiligo (SV) is a subtype of vitiligo refractory to treatment.
J Clin Aesthet Dermatol. 2020;13(6):46–47 by Alysha Colon, BS; Ryan Gillihan, MD; Kiran Motaparthi MD; and Maria Isabel Longo MD,PhD Ms. Colón is with the University of Florida College of Medicine in Gainesville, Florida. Drs. Gillihan, Motaparthi, and Longo are with the Department of Dermatology at the University of Florida in Gainesville, Florida. FUNDING: No
J Clin Aesthet Dermatol. 2020;13(5):48–53 by Paul Macklis, MS; Kevin Adams, BA; Jessica Kaffenberger, MD; Purnima Kumar, BDS MS PhD; Andrew Krispinsky, MD; and Benjamin Kaffenberger, MD Mr. Macklis is with the Ohio State University College of Medicine in Columbus, Ohio. Mr. Adams with with the University of Toledo College of Medicine in Toledo, Ohio.
J Clin Aesthet Dermatol. 2020;13(6):54–56 by Kami Lowery, BS; Theodore Rosen, MD; and Janet Malek, PhD Ms. Lowery is with Baylor College of Medicine in Houston, Texas. Dr. Rosen is with the Department of Dermatology at Baylor College of Medicine in Houston, Texas. Dr. Malek is with the Center for Medical Ethics and Health Policy
J Clin Aesthet Dermatol. 2020;13(6):57–58 by Selena R. Pasadyn, BA; Alexandria Haseley, MS, LGC; and Mahwish Irfan, MD Ms. Pasadyn is with the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. Ms. Haseley is with the Genomic Medicine Institute at the Cleveland Clinic in Cleveland, Ohio. Dr. Irfan is
Gardner-Diamond syndrome (GDS) is a psychological and dermatologic syndrome involving painful, ecchymotic, purpuric lesions that typically appear after a period of stress or minor trauma.